TECH - Bio-Techne Corporation
NEXT EARNINGS:
May 6, 2026
EPS Est: $0.55
|
Rev Est: $316.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.86
DETAILS
HIGH:
$79.00
LOW:
$62.00
MEDIAN:
$70.00
CONSENSUS:
$69.86
UPSIDE:
21.28%
Market Cap:
9.01B
Volume:
2,882,448
Avg Volume:
2,132,843
52 Week Range:
46.01-72.16
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.47
Last Dividend:
$0.32
Exchange:
NASDAQ
Country:
US
Employees:
3,100
IPO Date:
1989-02-09
EPS (TTM):
0.47
P/E Ratio:
110.41
Revenue (TTM):
1.22B
Total Assets:
2.56B
Total Debt:
444.06M
Cash & Equiv:
162.19M
Rev Growth (5Y):
10.6%
EPS Growth (5Y):
-20.7%
FCF Growth (5Y):
10.8%
ROCE:
4.5%
Debt/Equity:
0.23
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.46 | $0.43 | +7.0% | $295.9M | $316.6M | -6.5% |
| 2025-11-05 | $0.42 | $0.42 | -0.3% | $286.6M | $291.3M | -1.6% |
| 2025-08-06 | $0.53 | $0.50 | +6.0% | $317.0M | $294.6M | +7.6% |
| 2025-05-07 | $0.56 | $0.51 | +9.8% | $316.2M | $325.5M | -2.8% |
| 2025-02-05 | $0.42 | $0.38 | +10.5% | $297.0M | $317.5M | -6.5% |
| 2024-10-30 | $0.42 | $0.38 | +10.5% | $289.5M | $280.3M | +3.3% |
| 2024-08-07 | $0.49 | $0.49 | -1.0% | $306.1M | $306.5M | -0.1% |
| 2024-05-01 | $0.48 | $0.46 | +4.3% | $303.4M | $306.1M | -0.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.22B | 1.16B | 1.14B | 1.11B | 931.03M | 738.69M | 714.01M | 642.99M | 563.00M | 499.02M | 452.25M | 357.76M |
| Net Income | 73.40M | 168.10M | 285.26M | 272.05M | 140.41M | 229.30M | 96.07M | 125.35M | 77.29M | 104.48M | 107.73M | 110.95M |
| EPS | 0.47 | 1.07 | 1.81 | 1.73 | 0.91 | 1.50 | 0.64 | 0.84 | 0.52 | 0.70 | 0.73 | 0.75 |
| Total Assets | 2.56B | 2.70B | 2.64B | 2.29B | 2.26B | 2.03B | 1.88B | 1.59B | 1.56B | 1.13B | 1.06B | 862.49M |
| Total Debt | 444.06M | 419.54M | 454.96M | 325.97M | 420.55M | 433.53M | 505.16M | 339.00M | 349.90M | 133.76M | 116.05M | 12.95M |
| Cash & Equivalents | 162.19M | 151.79M | 180.57M | 172.57M | 199.09M | 146.62M | 100.89M | 121.99M | 91.61M | 64.24M | 54.53M | 318.57M |
| Operating Cash Flow | 287.56M | 298.98M | 254.39M | 325.27M | 352.16M | 205.22M | 181.62M | 170.37M | 143.45M | 143.87M | 139.36M | 136.76M |
| Free Cash Flow | 256.55M | 236.10M | 216.15M | 280.36M | 307.86M | 153.47M | 156.21M | 149.43M | 128.27M | 126.97M | 119.45M | 122.94M |
| FCF per Share | 1.63 | 1.50 | 1.38 | 1.79 | 1.99 | 1.00 | 1.03 | 1.00 | 0.86 | 0.85 | 0.81 | 0.83 |
| Book Value | 1.92B | 2.07B | 1.97B | 1.70B | 1.56B | 1.38B | 1.17B | 1.08B | 950.83M | 879.28M | 846.93M | 795.26M |
| Cash & ST Investments | 162.19M | 152.86M | 204.31M | 247.03M | 231.55M | 270.89M | 166.03M | 181.75M | 157.71M | 95.83M | 110.92M | 363.35M |
| ROC Equity | 0.04 | 0.08 | 0.15 | 0.16 | 0.09 | 0.17 | 0.08 | 0.12 | 0.08 | 0.12 | 0.13 | 0.14 |